A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia
Clinical trial NCT01683279 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01683279
- Sponsor
- Seattle Children's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-25
- Primary completion
- 2015-01-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.